 So if we don't have a continued flow of new genericizing medicines to keep the generic industry swimming, they won't be able to keep making all the other stuff. Same thing for everybody else. You're not going to invest in buffer stocks or anything else if it's a flat to declining market that is becoming less and less relevant as newer medicines come along.